VICTOR J THANNICKAL, MD
Osteopathic Medicine at 6 Ave, Birmingham, AL

License number
Alabama 29563
Category
Osteopathic Medicine
Type
Pulmonary Disease
License number
Alabama 4301079260
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Alabama 4301079260
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
6Th Ave S, Birmingham, AL 35233
Phone
(205) 801-8000
(205) 731-9701
(205) 297-9411 (Fax)

Personal information

See more information about VICTOR J THANNICKAL at radaris.com
Name
Address
Phone
Victor Thannickal, age 63
4146 Somerset Rdg, Birmingham, AL 35242
(734) 347-4515
Victor Thannickal
Birmingham, AL
(205) 747-0899
Victor J Thannickal, age 63
4146 Somerset Cir, Birmingham, AL 35242
(205) 747-0899

Organization information

See more information about VICTOR J THANNICKAL at bizstanding.com

Victor J Thannickal MD

1900 University Blvd Tht 422, Birmingham, AL 35294

Categories:
Physicians & Surgeons
Phone:
(205) 934-4011 (Phone)

Professional information

Victor J Thannickal Photo 1

Dr. Victor J Thannickal, Birmingham AL - MD (Doctor of Medicine)

Specialties:
Critical Care Medicine, Pulmonology
Address:
UAB Hosp Pulmonary/Critical Cr
2000 6Th Ave S, Birmingham 35233
(205) 934-5400 (Phone)
Certifications:
Critical Care Medicine, 2005, Internal Medicine, 1990, Pulmonary Disease, 1994
Awards:
Healthgrades Honor Roll
Languages:
English, Malayalam
Hospitals:
UAB Hosp Pulmonary/Critical Cr
2000 6Th Ave S, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
Education:
Medical School
Oral Roberts University, School Of Medicine
Graduated: 1987


Victor Thannickal Photo 2

Compositions And Methods For Diagnosing And Treating Fibrotic Disorders

US Patent:
2012014, Jun 7, 2012
Filed:
Jul 19, 2010
Appl. No.:
13/384108
Inventors:
Victor J. Thannickal - Birmingham AL, US
Louise Hecker - Birmingham AL, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/713, A61P 9/00, A61K 39/395
US Classification:
4241301, 514 44 A
Abstract:
The present invention relates to biomarkers, therapeutic targets, and therapeutic agents for treating and diagnosing firotic disorders. In particular, the present invention relates to diagnosis, drug screening, and therapeutic targeting of NOX4 biomarkers of pulmonary fibrosis and other fibrotic diseases and conditions.